Puma Biotechnology, Inc.PBYINASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank79
3Y CAGR+1.9%
5Y CAGR+8.1%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+1.9%/yr
vs +12.3%/yr prior
5Y CAGR
+8.1%/yr
Recent deceleration
Acceleration
-10.5pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$58.23M-9.6%
2024$64.40M+2.7%
2023$62.68M+13.8%
2022$55.09M-13.5%
2021$63.70M+61.8%
2020$39.37M+7.0%
2019$36.81M+6.4%
2018$34.60M+517.9%
2017$5.60M+387.4%
2016$1.15M-